MONTPELIER, VT — Vermont Governor Phil Scott has signed into law a bill to expand the state’s medical marijuana program. Senate Bill 16, which received overwhelming support in both chambers of the state legislature, was aimed at improving access to medical marijuana in Vermont. Among the changes made by the new law: Patients and caregivers […]
Drug smuggler who attempted to bring £25000 worth of cannabis into UK in rum …
A drug smuggler who attempted to bring £25,000 worth of cannabis into the UK in rum cake boxes has been jailed. Lee Love, of Cartwright Street, Audenshaw , attempted to pass through customs at Birmingham Airport in a wheelchair being pushed by an …
Read more on Manchester Evening News
Introducing the Tucson Weedly Cannabis Bowl
Now, it's time for our MMJ-card-carrying readers to tell us—and the rest of the city—what they think about the local cannabis scene. Editor Mari Herreras puts it like this: Medical marijuana patients we talk to never hesitate to tell us about that …
Read more on Tucson Weekly
San Francisco, CA (PRWEB) May 21, 2015
It can be difficult to start a business of any nature. Venturing into the legal marijuana industry, however, will most certainly lead to numerous challenges not encountered by traditional businesses. Green Rush Review, a marijuana business news website, identifies nine cannabis-specific factors that startups need to take into consideration.
When starting a cannabis related business, one not only has to consider whether marijuana is legal in a particular state, but also has to check for any restrictions on cultivating or setting up shop. In Oregon, for instance, dispensaries may not be located within 1,000 feet of a primary or secondary school. Building landlords may also have opposing views on starting a legal cannabis business on their property.
State laws outline numerous requisites needed for a cannabis company to operate. According to a Mashable article, such investments in Colorado include a digital seed-to-sale tracking program, 24-hour video surveillance of facilities, as well as a quarantine section for edibles.
Marketing cannabis businesses can be tricky, as they do not have the same advertising options that traditional businesses enjoy. According to Marijuana Business Daily, cannabis companies are restricted from advertising in TV, radio, print, billboards, Internet videos, radio shows, pop-ups, and flyers or leaflets among others. One therefore needs to be both careful and creative when marketing a cannabis-related company.
Storing Money and Paying Bills
As marijuana is still deemed federally illegal, marijuana businesses cannot typically avail of bank services. Cannabis entrepreneurs are thus left with limited options, and are generally left to transact in cash. Unfortunately, storing money in cash can be both a security and accountability risk. According to The New York Times, pot businesses are left to store their cash in safes, carry them in brown paper bags, and ferry them around by armed guards and armored vehicles.
While the federal government may see pot as illegal, the people selling it are still left to pay their taxes. A CNBC article reports that the IRS does not allow the usual business deductions under section 280E. While the federal tax code allows deductions for the cost of growing recreational marijuana in Washington and Colorado, it does not allow deductions for the cost of selling it.
The marijuana industry is growing fast, and Esquire reports that jobs in the industry are everywhere. The challenge, however, is meeting special personnel requirements and finding employees who fit in with the company culture.
A marijuana business may benefit greatly from supporting or joining associations, organizations, federations, and clubs that promote an interest in the marijuana industry. There are numerous groups to choose from, including the National Cannabis Industry Association, NORML, and High Times.
There is always the risk of federal prosecution, even if marijuana is legal in a particular state. Although federal prohibition is not enforced on a state level, this may change at any point in time. A contingency plan must be developed in order to protect a business from a change in circumstances.
According to The Milbank Quarterly, tobacco companies have expressed interest in marijuana and marijuana legalization since the 1970s, and are modifying corporate planning strategies to prepare for consumer demand in the future. At present, big drugstore chains, cigarette companies, and other large businesses are forbidden from entering the still-developing marijuana market. At some point, however, this may change when the market normalizes and they wipe out small marijuana businesses.
GreenRushReview.com strives to be a convenient and reliable online resource for all marijuana consumers, entrepreneurs, and investors. The website aims to provide the general public with extensive coverage on news, opinions, and events on the multi-billion marijuana industry and culture in North America, including industry stocks, prices, implications, trend developments, investment news and legislation.
GreenRushReview.com sifts through the abundance of material on the cannabis industry only publishing high-quality information that is significant to its readers.
GreenRushReview.com is part of a portfolio of cannabis industry sites which includes http://www.bestmedicalmarijuanastocks.com (top medical marijuana company news) & http://www.marijuanastocksreport.com (cannabis small cap stock news).
Companies seeking exposure on GreenRushReview.com can contact editorial(at)greenrushreview(dot)com for more information.
Find More Cannabis Press Releases
Schofield, WI (PRWEB) March 20, 2014
PuraMed BioScience®, Inc., (OTCBB:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, confirmed today that it is aggressively investigating the development of cannabinoid and hemp-based products to add to its line of medicinal formulations.
PuraMed BioScience initially intends to manufacture THC-free formulations that create medicinal compounds that don’t produce the “high” associated with cannabis containing THC. Scientific research has shown that cannabinoids can be formulated to effectively treat conditions such as multiple sclerosis, Crohn’s disease, pain, neurodegenerative disorders, epilepsy, arthritis and combat the effects of cancer chemotherapy.
“Integrating cannabinoid-based medications into our product line makes sense with what we are already doing,” said Russell Mitchell, CEO of PuraMed BioScience. “Cannabis has been used medicinally for centuries. It has only been in the last 100 years that its schedule 1 drug status and the abuse of this product for non-medicinal purposes has detracted from its medicinal benefits. Just one look at PubMed and you will see over 400 medical articles that report that it provides a viable treatment to neurologic problems, inflammatory diseases, and pain.
“Due to recent changes in the legality and availability of cannabinoids, we believe the future looks extremely bright for the development of highly effective and safe treatments incorporating these hemp derived compounds,” said Mitchell.
Scientific evidence continues to grow as to the effectiveness and safety of certain cannabinoids used to treat a number of disease states. In his article, ‘I am doubling down’ on medical marijuana, published on CNN Health, Dr. Sanjay Gupta, practicing neurosurgeon and CNN Chief Medical Correspondent, confirms his previous article apologizing for dismissing the plant’s potential.
Dr. Gupta has seen first-hand the benefit of this substance in the lives of people as shown in his documentaries Weed and Weed2, which recently aired on CNN. During his documentaries, Dr. Gupta stated that, unlike some prescription pain relievers, no one has died from an overdose of cannabis.
Even the United States government holds patents on cannabis-based formulations.
PuraMed BioScience has been investigating this market for nearly two years and found that cannabinoids offer a structure and function that fits ideally with several of its existing technologies. “We have been following the studies that currently are being conducted in Israel,” said Mitchell.
The company has researched the potential efficacy of cannabinoid-based pain treatment for patients with rheumatoid arthritis and chronic back pain and found that there was evidence of a high probability of success. PuraMed believes that a combination of cannabinoids with other natural compounds can provide superior results while avoiding the often severe side effects of many of the prescription treatments.
“The results of our preliminary research combined with the fact that the US cannabis market is expected to grow to over $ 10 billion by 2018, are strong reasons to aggressively develop a cannabis and hemp-based product line,” said Mitchell. “Development of these products will continue our mission of providing safe, effective products that use natural ingredients.
“We are particularly interested in the development of a formulation that will help veterans who are suffering the effects of Post Traumatic Stress Disorder (PTSD),” said Mitchell. “An effective PTSD formulation in addition to our LipiGesic® M migraine product would allow us to provide veterans with two effective medications to relieve these debilitating conditions.”
According to reports, on March 14, 2014, Suzanne Sisley, a lead researcher at the University of Arizona received approval from the Public Health Service, a branch of the US Department of Health & Human Services to research medical marijuana’s effectiveness in the treatment of PTSD. This was the second of three approvals necessary to conduct the research. The research has been approved by the US Food and Drug Administration (FDA) and is awaiting approval from the Drug Enforcement Administration (DEA).
At this point in time, six states approve the use of medical cannabis for PTSD.
PuraMed BioScience intends to become a leader in the cannabinoid-based medicine market utilizing its proven ability to develop and produce highly effective plant based medicines. The company has historically used scientific and clinical studies to prove the efficacy and safety of its products. PMBS expects to lead the way in conducting the same level of validated science for any product that contains cannabinoids.
“We’ve produced a highly effective acute migraine medication using feverfew and ginger that has been clinically tested and found to provide efficacies that perform better than its prescription counterparts,” said Mitchell. “We have faced an uphill battle with the adoption of homeopathic drugs in the mainstream, but we see that changing as well.”
In the March 24, 2014 issue of Woman’s World, LipiGesic® M is featured in an article entitled, “No more migraine pain!” The combination of feverfew and ginger was a treatment for migraine was also mentioned in “Nature’s First Aid Kit” which appeared in the February 2014 issue of O The Oprah Magazine.
“Publication in these magazines proves that the public is beginning to embrace the idea of “natural and safe” medications made with homeopathic formulations,” said Mitchell. “As more of the public embraces natural medicinal products, we will continue to provide formulations that operate with the highest level of efficacy and safety, which will allow people to choose a natural alternative without compromising treatment outcomes.”
About LipiGesic M:
Results of a double-blind, placebo-controlled clinical trial for LipiGesic®M show LipiGesic M is a highly effective treatment for acute migraine. The study was published in the July 2011 issue of the top-tier medical journal, Headache: The Journal of Head and Face Pain. In addition to LipiGesic M, the Company also has plans to launch LipiGesic® H, tension headache remedy, as well as LipiGesic® PM, a remedy for insomnia and other sleep disorders.
This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO
Marijuana incorporated: cannabis eases into a billion-dollar business high
Stuart Tomc, vice-president of Human Nutrition at CannaVest, which develops and sells hemp-based products, offers a sample at the Expo at the Hilton Chicago. Photograph: …. “It means we need to grow it, and produce it and package it all inside each …
Read more on The Guardian
Stevia Corp. Discusses Partnership Plans While Continuing to Implement a …
Although it is legal to import and sell industrial hemp products in the U.S., it is not yet legal to commercially grow industrial hemp in the U.S. The 2013 farm bill was signed into law in February 2014 and contained a hemp amendment, Sec. 7606 …
Read more on Digital Journal
Why can't Texans grow hemp?
Shouldn't Texas farmers be allowed to grow and sell hemp? Farmers in Colorado, and university researchers in both Kentucky and Colorado, recently harvested their first legal hemp crops, just months after Congress voted to allow hemp cultivation where …
Read more on Chron.com
Berkeley, CA (PRWEB) December 11, 2013
Cannabis Now Magazine recently became the only cannabis magazine available on iTunes, significant because of Apple’s famously “family-friendly” attitude towards the items in its store. Its historic inclusion is proof of the magazine’s success in bringing responsible dialogue to the public. With the passage of legislation in two states and more on the horizon, cannabis and the issues surrounding its legalization and decriminalization have taken the nation by storm. Founded in in 2010, the magazine now has the opportunity to reach a global audience.
The magazine itself has faced setbacks associated with the cannabis movement. After putting out its first two issues in Montana, the medical marijuana laws in the state became vastly restrictive preventing, among other things, advertising of any kind. After losing most of its advertising base virtually overnight, the magazine changed its headquarters and expanded to Berkeley, Calif. This choice proved to be fruitful as the publication was able to expand to bi-monthly print issues and partner with some of the biggest names in the industry, including Harborside Health Center, Oaksterdam University and the Northwest Patient Resource Center.
Angela Bacca, a Bay Area-based journalist who continues to work closely with the Guru of Ganja, Ed Rosenthal, recently joined the Cannabis Now Team. Bacca works as the managing editor and brings a wealth of knowledge, with a specialty in investigative journalism and legal issues surrounding medical marijuana cases.
The magazine has been widely praised by industry professionals including Harborside co-founder and Executive Director Steve DeAngelo who thanked the publication for its “good work bringing the truth about cannabis.” In addition, a recent article featuring Jamen Shively, the Seattle-based entrepreneur who hopes to open a national chain of marijuana dispensaries, resulted in Shively working closing with the magazine to ensure the issues reached those in his wide cannabis network.
Cannabis Now Magazine is set to release its ninth issue at the end of this month. The print edition is available online as well as in Barnes & Noble, 7-Eleven, dispensaries, head shops, smoke shops, bookstores and numerous other outlets around the country. The magazine will also be distributed at HempCon in San Jose, Calif. on Jan 17 – 19, Champs in Las Vegas Jan. 21 – 23 and the BIG Industry 2014 Cannabis Cup in Denver, Colo. April 16 – 20.
About the Company:
By including only responsible content, Cannabis Now Magazine’s publishers hope to enlighten and educate the public on the legitimate and beneficial side of cannabis. The magazine focuses on the latest news, politics, horticultural advancements, social change, economic trends and medical information.
Dallas, TX (PRWEB) August 28, 2014
The American Seed & Oil Company, a subsidiary of Algae International Group, Inc. (OTC: ALGA), announced last week a strategy launched last January to enter the existing U.S. $ 500 million Industrial Hemp market.
The announcement can be found on Bloomberg BusinessWeek:
The Company subsequently released details to expand its existing hemp farming operations in Vermont:
Today the Company made public its efforts to expand into Colorado.
In June this year, Management participated in the first annual Weed Stock Conference in Denver, Colorado.
At the Weed Stock Conference, the Company engaged a number of local parties in early negotiations to establish hemp and marijuana farms in Colorado. The Company is also exploring retail and wholesale operation pilots in addition to possible cannabis tourism projects.
To learn more about the Company’s cannabis business strategy and the progress to date in the development of that strategy, visit the Company’s new American Seed & Oil Company website. In particular, read ‘The Introduction Of The American Seed & Oil Company’ found on the website to specifically learn about the Company’s current hemp crop and all three new cannabis industry subsidiaries.
About Algae International Group, Inc. and The American Seed & Oil Company, Inc.
(OTC: ALGA) Algae International Group, Inc. first became interested in the cannabis opportunity last year while attempting to build a business to produce bio diesel from cold pressed algae oil. While the ‘promise’ of the cannabis market is great, the path to achieving the ‘promise’ is unclear. An incubator improves the odds of success in an early and rapidly evolving market by building multiple, complimentary businesses with an initial strategy to explore market opportunity rather than to attempt seizing market opportunity prematurely. Accordingly, the Company is starting with three incubated subsidiaries, and will continue to explore the introduction of additional complimentary subsidiaries. As subsidiaries develop to a viable stage of independence, the Company will spinoff such subsidiaries creating independent ROI opportunities for parent shareholders.
Learn more about the incubated subsidiaries at http://www.AmericanSeedandOil.com.
Red Lake Band could get into marijuana, industrial hemp business
These plants are medicine, and to not make these things available is criminal.” The tribal council voted to initiate a feasibility study of both industrial hemp and medicinal marijuana opportunities. WDAZ reports a referendum will bring the decision to …
Read more on Rick Kupchella’s BringMeTheNews
Supporters of hemp cultivation in the United States are one step closer to seeing that happen. Governor Hickenlooper signed SB13-241 into law. The legislation authorized the state of Colorado to begin distributing hemp licenses.
While the fight is slow, hemp supporters grow more hopeful with each step forward.
Senator Rand Paul says he has a plan in Congress to legalize industrial hemp production in the US, or a seek a waiver for Kentucky because as he put it, ‘Kentucky should not be left behind.’
Video Rating: 5 / 5